Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/000520 stock hub

KRX/000520 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/000520is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

189.4B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/000520

In the news

Latest news · KRX/000520

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/En/a

P25 12P50 23.1P75 39.5

ROE-22.4

P25 -17.1P50 0.7P75 8.5

ROIC-8.1

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/000520 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

KRW

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	583
Enterprise value	KRW 347B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7000520007
Last refreshed	2026-05-10
Market cap	KRW 189.4B
Price	KRW 8,920
Price currency	KRW
Rev Per Employee	360,640,605.45x
Sector	Healthcare
Sic	2834
Symbol	krx/000520
Website	https://www.samil-pharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-18.3%
EV Earnings	-10.01x
EV/FCF	-50.37x
EV/Sales	1.65x
FCF yield	-3.64%
P/B ratio	1.42x
P/S ratio	0.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-11.39%
EBITDA Margin	-7.01%
Gross margin	36.68%
Gross Profit	KRW 77.1B
Gross Profit Growth	-4.69%
Gross Profit Growth Q	-5.27%
Gross Profit Growth3 Y	4.55%
Gross Profit Growth5 Y	9.48%
Net Income	KRW -34.7B
Net Income Growth Years	0%
Pretax Margin	-17.67%
Profit Margin	-16.49%
Profit Per Employee	KRW -59.5M
ROA	-3.9
Roa5y	-0.36
ROCE	-12.84
ROE	-22.41
Roe5y	-6.62
ROIC	-8.09
Roic5y	-1.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.19%
Cagr15y	10.76%
Cagr1y	-27.79%
Cagr20y	2.57%
Cagr3y	4.4%
Cagr5y	1.04%
Div CAGR10	0.65%
Div CAGR3	2.17%
Div CAGR5	1.3%
EPS Growth Years	0
FCF Growth Q	525.16%
OCF Growth	-78.06%
OCF Growth Q	118.49%
OCF Growth10 Y	-15.1%
OCF Growth3 Y	-48.48%
OCF Growth5 Y	-40.74%
Revenue Growth	-4.3x
Revenue Growth Q	-8.28x
Revenue Growth Years	0x
Revenue Growth3 Y	5.38x
Revenue Growth5 Y	11.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.55
Assets	KRW 371.6B
Cash	KRW 6.4B
Current Assets	KRW 82B
Current Liabilities	KRW 185.2B
Debt	KRW 164B
Debt Equity	KRW 1.23
Debt FCF	KRW -23.81
Equity	KRW 133.3B
Interest Coverage	-2.73
Liabilities	KRW 238.3B
Long Term Assets	KRW 289.6B
Long Term Liabilities	KRW 53.2B
Net Cash	KRW -157.6B
Net Cash By Market Cap	KRW -83.23
Net Debt Equity	KRW 1.18
Tangible Book Value	KRW 129.5B
Tangible Book Value Per Share	KRW 6,102
WACC	5.51

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.44
Inventory Turnover	3.83
Net Working Capital	KRW 31.6B
Quick ratio	0.23
Working Capital	KRW -103.2B
Working Capital Turnover	KRW -3.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-18.05%
Dividend per share	KRW 0
Last Dividend	KRW 72.73

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	140.79%
1Y total return	-27.77%
200-day SMA	10,118.6
3Y total return	13.78%
50-day SMA	9,877.4
50-day SMA vs 200-day SMA	50under200
5Y total return	5.3%
All Time High	29,000
All Time High Change	-69.24%
All Time High Date	2018-04-10
All Time Low	507.6
All Time Low Change	1,657.45%
All Time Low Date	1998-06-16
ATR	442.9
Beta	0.43
Beta1y	0.18
Beta2y	0.39
Ch YTD	-7.95
High	9,200
High52	13,300
High52 Date	2025-05-15
High52ch	-32.93%
Low	8,900
Low52	8,560
Low52 Date	2026-01-22
Low52ch	4.21%
Ma50ch	-9.69%
Price vs 200-day SMA	-11.85%
RSI	38.02
RSI Monthly	45.35
RSI Weekly	40.37
Sharpe ratio	-0.62x
Sortino ratio	-0.82
Total Return	-18.05%
Tr YTD	-7.95
Tr15y	362.88%
Tr1m	-5.61%
Tr1w	-2.83%
Tr3m	-17.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -23.9B
Operating margin	-11.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,996,803%
Net Borrowing	15,287,689,030
Shares Insiders	24.5%
Shares Institutions	3.73%
Shares Out	21,229,653
Shares Qo Q	0%
Shares Yo Y	18.05%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -6.9B
Average Volume	218,004.85x
Bv Per Share	6,277.2
CAPEX	KRW -7.5B
Ch10y	115.6
Ch15y	253
Ch1m	-5.61
Ch1w	-2.83
Ch1y	-27.77
Ch20y	10.56
Ch3m	-17.48
Ch3y	13.78
Ch5y	3.28
Ch6m	-15.13
Change	-2.09%
Change From Open	-2.3
Close	9,110
Days Gap	0.22
Depreciation Amortization	9,197,008,950
Dollar Volume	1,639,656,560
Earnings Date	2026-05-14
EBIT	KRW -23.9B
EBITDA	KRW -14.7B
EPS	KRW -1,633
F Score	3
FCF	KRW -6.9B
FCF EV Yield	-1.99x
FCF Per Share	KRW -324
Financing CF	8,650,067,560
Fiscal Year End	December
Founded	1,947
Income Tax	KRW -2.5B
Investing CF	-7,968,662,570
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2023-03-24
Last Split Type	Forward
Ma150	10,019.3
Ma150ch	-10.97%
Ma20	9,503
Ma20ch	-6.13%
Net CF	1,275,129,080
Next Earnings Date	2026-05-14
Open	9,130
P OCF Ratio	333.3
Position In Range	6.67
Ppne	242,715,070,800
Price Date	2026-05-08
Ptbv Ratio	1.46
Relative Volume	0.84x
Revenue	210,253,472,980x
Tax By Revenue	-1.19x
Tr20y	65.94%
Tr6m	-15.13%
Volume	183,818
Z Score	0.56

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/000520 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/000520 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/000520?

Insider, institutional, and short-interest positioning.

Institutional ownership

+3.7%

Share of float held by funds and institutions

Insider ownership

+24.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+18.1%

Negative means the company is buying back shares.

Technical

KRX/000520 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.0

Neutral momentum band

Price vs 200-day MA

-11.8%

50/200-day relationship not available

Beta (5Y)

0.43

Less volatile than the market

Sharpe ratio

-0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/000520

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/000520 stock rating?

krx/000520 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/000520 analysis?

The full report lives at /stocks/krx/000520/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/000520?

The latest report frames krx/000520 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/000520 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.